Company: DHR
Filing Date: 2025-07-22
Form Type: 10-Q
Source: 0000313616-25-000153
Chunk: 13

Company: DANAHER CORP /DE/
Filing Date: 2025-07-22
Form: 10-Q
Item: Item 1
Chunk 13
---
onth Period Ended June 28, 2024:Sales$1,713 $1,770 $2,260 $— $5,743 Less:Depreciation(35)(41)(100)(2)(178)Amortization of intangible assets(214)(140)(48)— (402)Other segment expenses(c)(1,002)(1,356)(1,556)(81)(3,995)Operating profit (loss)$462 $233 $556 $(83)$1,168 

10

BiotechnologyLife SciencesDiagnosticsOther(a)TotalFor the Six-Month Period Ended June 27, 2025:Sales$3,462 $3,457 $4,758 $— $11,677 Less:Depreciation(72)(90)(200)(4)(366)Amortization of intangible assets(441)(299)(96)— (836)Impairments(b)(15)(432)— — (447)Other segment expenses(c)(1,962)(2,674)(3,190)(168)(7,994)Operating profit (loss)$972 $(38)$1,272 $(172)$2,034 For the Six-Month Period Ended June 28, 2024:Sales$3,237 $3,515 $4,787 $— $11,539 Less:Depreciation(77)(79)(197)(4)(357)Amortization of intangible assets(432)(281)(96)— (809)Other segment expenses(c)(1,941)(2,687)(3,108)(157)(7,893)Operating profit (loss)$787 $468 $1,386 $(161)$2,480 (a) Other consists of unallocated corporate costs and other costs not considered part of management’s evaluation of reportable segment operating performance.(b) For information on the impairments, refer to Note 8. (c) Other segment expenses for each reportable segment include cost of sales, selling, general and administrative (“SG&A”) expenses and research and development (“R&D”) expenses, excluding in each case depreciation, amortization of intangible assets and impairments.  Included within these categories of expenses are overhead expenses, stock compensation expense, restructuring charges and allocated corporate expenses. The following table presents identifiable assets as of June 27, 2025 and December 31, 202